Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia

Humans infected with SARS-CoV-2 may develop COVID-19, which manifests across a wide spectrum of clinical severity ranging from mild upper respiratory tract illnesses to diffuse viral pneumonia, causing acute respiratory failure. Many therapies have been tested for their efficacy in treating COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Basheer, Maamoun, Saad, Elias, Shlezinger, Dorin, Assy, Nimer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622396/
https://www.ncbi.nlm.nih.gov/pubmed/34822419
http://dx.doi.org/10.3390/metabo11110761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622396/
https://www.ncbi.nlm.nih.gov/pubmed/34822419
http://dx.doi.org/10.3390/metabo11110761

Ejemplares similares